TACROLIMUS IMPURITY H
UNII XB5YB7L8RD

Substance Identification & Data

This profile provides standardized clinical and technical data for Tacrolimus Impurity H, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XB5YB7L8RD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 143210-33-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XB5YB7L8RD

CAS Registry Number

143210-33-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TACROLIMUS IMPURITY H

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C43H69NO11

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

LUBLZMAEBCCRLW-HTLAODBJSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

101342455

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N1([C@@H](CCCC1)C(=O)O[C@H](\C(=C\[C@H]2C[C@H]([C@@H](CC2)O)OC)\C)[C@@H]([C@H](CC([C@@H](/C=C(/C[C@@H](C[C@@H]([C@H]3OC([C@@H](C[C@@H]3OC)C)=O)OC)C)\C)CC=C)=O)O)C)C=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tacrolimus Impurity H. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

TACROLIMUS IMPURITY H

TACROLIMUS MONOHYDRATE IMPURITY H [EP IMPURITY]

Systematic Nomenclature

(1E,3S,4R,5S,8R,9E,12S,14S)-5-HYDROXY-1-((1R,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-14-METHOXY-14-((2R,3S,5R)-3-METHOXY-5-METHYL-6-OXOOXAN-2-YL)-2,4,10,12-TETRAMETHYL-7-OXO-8-(PROP-2-EN-1-YL)TETRADECA-1,9-DIEN-3-YL (2S)-1-FORMYLPIPERIDINE-2-CARBOXYLATE

SYS

2-PIPERIDINECARBOXYLIC ACID, 1-FORMYL-, (1S,2R,3S,6R,7E,10S,12S)-3-HYDROXY-1-((1E)-2-((1R,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-METHYLETHENYL)-12-METHOXY-2,8,10-TRIMETHYL-5-OXO-6-(2-PROPEN-1-YL)-12-((2R,3S,5R)-TETRAHYDRO-3-METHOXY-5-METHYL-6-OXO-2H-PYRAN-2-YL)-7-DODECEN-1-YL ESTER, (2S)-

SYS

2-PIPERIDINECARBOXYLIC ACID, 1-FORMYL-, 3-HYDROXY-1-(2-(4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-METHYLETHENYL)-12-METHOXY-2,8,10-TRIMETHYL-5-OXO-6-(2-PROPENYL)-12-(TETRAHYDRO-3-METHOXY-5-METHYL-6-OXO-2H-PYRAN-2-YL)-7-DODECENYL ESTER, (2R-(2.ALPHA.(1S*((E(1R*,3R*,4R*)),(S*)),2R*,3S*,6R*,7E,10S*,12S*),3.BETA.,5.BETA.))-

SYS

External Clinical & Regulatory Resources

Previous UNIIXB5SQX2RBW

Next UNIIXB6RQ16Y55